Autoimmune Disease Diagnostics Market Report
First published: 21 October 2024 | Last updated: 28 May 2026 | Report Code: autoimmune-disease-diagnostics
Autoimmune Disease Diagnostics Market — USD $8.7 Billion in 2023, Growing to USD 17.78null by 2033 at 7.2% CAGR
This report provides an in-depth analysis of the Autoimmune Disease Diagnostics market, emphasizing market trends, growth forecasts, and competitive dynamics from 2023 to 2033.
Key Takeaways
- Global market projected from $8.70 Billion in 2023 to $17.78 Billion in 2033 at a 7.2% CAGR.
- North America is the largest region, growing from $3.38 Billion in 2023 to $6.91 Billion in 2033.
- North America is largest regional market; Latin America is regional market region based on implied CAGR across 2023 to 2033.
- Regional shifts and technology adoption drive demand across hospitals, clinical laboratories, and research institutions.
- Top companies include Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Roche Diagnostics, and Becton, Dickinson and Company (BD).
Autoimmune Disease Diagnostics Market Report — Executive Summary
Regional analysis shows North America as largest market and Latin America as fastest-growing region by implied CAGR. The Autoimmune Disease Diagnostics Market Report outlines expanding demand driven by improvements in laboratory technology, greater awareness of autoimmune conditions, and rising healthcare expenditures. Diagnostic categories span laboratory tests, molecular diagnostics, imaging, and point-of-care approaches, while technologies range from traditional assays to advanced and automated platforms. End users include hospitals, clinical laboratories, home care settings, and research institutions. Regional performance varies: North America shows the highest market value, and Latin America is noted as the regional market region. Leading firms such as Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Roche Diagnostics, and Becton, Dickinson and Company (BD) influence innovation and availability. The report integrates primary interviews and secondary sources to present validated insights for stakeholders planning product development, market entry, or partnerships.
Key Growth Drivers
- Advances in laboratory and molecular diagnostic technologies expanding test accuracy and throughput.
- Increased healthcare spending and infrastructure investments supporting diagnostic capacity and adoption.
- Rising public and clinical awareness of autoimmune disorders prompting more testing and early detection.
- Shift toward decentralized testing and point-of-care solutions reducing turnaround times and widening access.
- Ongoing research initiatives and product launches by major companies enhancing diagnostic portfolios.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $8.70 Billion |
| CAGR (2023-2033) | 7.2% |
| 2033 Market Size | $17.78 Billion |
| Top Companies | Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Roche Diagnostics, Becton, Dickinson and Company (BD) |
| Published Date | 21 October 2024 |
| Last Modified Date | 28 May 2026 |
Autoimmune Disease Diagnostics Market Overview
Customize Autoimmune Disease Diagnostics Market Report market research report
- ✔ Get in-depth analysis of Autoimmune Disease Diagnostics market size, growth, and forecasts.
- ✔ Understand Autoimmune Disease Diagnostics's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Autoimmune Disease Diagnostics
What is the Market Size & CAGR of Autoimmune Disease Diagnostics Market Report market in 2023?
Autoimmune Disease Diagnostics Industry Analysis
Autoimmune Disease Diagnostics Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Autoimmune Disease Diagnostics Market Report Market Analysis Report by Region
Europe Autoimmune Disease Diagnostics Market Report:
Europe grows from $2.56 Billion in 2023 to $5.24 Billion in 2033. Regional momentum is linked to increased diagnostic uptake, regulatory focus on test accuracy, and investments in laboratory modernization and molecular technologies.Asia Pacific Autoimmune Disease Diagnostics Market Report:
Asia Pacific grows from $1.6 Billion in 2023 to $3.27 Billion in 2033. Expansion is driven by rising healthcare expenditure, broader access to diagnostic services, and technology adoption in hospitals and clinical laboratories.North America Autoimmune Disease Diagnostics Market Report:
North America is largest regional market, rising from $3.38 Billion in 2023 to $6.91 Billion in 2033. This growth reflects robust clinical infrastructure, widespread adoption of advanced diagnostics, and substantial healthcare investment supporting testing capacity.South America Autoimmune Disease Diagnostics Market Report:
Latin America is fastest-growing region by implied CAGR, increasing from $0.18 Billion in 2023 to $0.38 Billion in 2033. The region is identified as the fastest-growing market, with growth supported by expanding diagnostic infrastructure and increasing awareness of autoimmune disorders.Middle East & Africa Autoimmune Disease Diagnostics Market Report:
Middle East and Africa grows from $0.98 Billion in 2023 to $2 Billion in 2033. Growth factors include gradual improvements in healthcare facilities, growing laboratory capabilities, and adoption of new diagnostic techniques.Tell us your focus area and get a customized research report.
Research Methodology
Autoimmune Disease Diagnostics Market Analysis By Test Type
The Autoimmune Disease Diagnostics market by test type is dominated by laboratory tests, with a market size of USD 5.49 billion in 2023, projected to increase to USD 11.22 billion by 2033, accounting for 63.07% share. Other significant segments include molecular diagnostics valued at USD 2.46 billion and imaging techniques at USD 0.76 billion in 2023, growing accordingly to USD 5.02 billion and USD 1.55 billion by 2033.
Autoimmune Disease Diagnostics Market Analysis By Automation Level
Market segmentation by level of automation shows significant demand for fully automated diagnostics, projected to grow from USD 0.76 billion in 2023 to USD 1.55 billion by 2033, representing an 8.7% market share. Semi-automated diagnostics also see growth, valuing USD 2.46 billion in 2023 and expected to reach USD 5.02 billion by 2033.
Autoimmune Disease Diagnostics Market Analysis By End Users
Hospitals remain the leading end-user segment for Autoimmune Disease Diagnostics with a market valuation of USD 4.51 billion in 2023, expected to grow to USD 9.22 billion by 2033, capturing 51.82% of the market share. Clinical laboratories and research institutions also form significant portions of the market, reflecting ongoing diagnostic innovation and testing needs.
Autoimmune Disease Diagnostics Market Analysis By Technology
In terms of technology, traditional diagnostic techniques comprising manual diagnostics account for USD 5.49 billion in 2023, projected to remain stable at a 63.07% market share. Advanced diagnostic techniques are expected to gain traction, increasing from USD 2.46 billion in 2023 to USD 5.02 billion by 2033.
Autoimmune Disease Diagnostics Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Autoimmune Disease Diagnostics Industry
Abbott Laboratories:
Abbott is a global healthcare company focusing on diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. They are at the forefront of innovation in autoimmune diagnostics.Thermo Fisher Scientific:
Thermo Fisher Scientific provides analytical instruments, reagents, and consumables for diagnostics and research. They actively develop solutions for autoimmune disease testing.Siemens Healthineers:
Siemens Healthineers specializes in imaging and diagnostic devices and solutions that significantly improve the efficiency of autoimmune disease diagnostics.Roche Diagnostics:
Roche is a leading player in the healthcare sector, focusing on innovative diagnostics solutions and tests that address various autoimmune diseases.Becton, Dickinson and Company (BD):
BD is known for its contributions to medical devices and diagnostics, focusing on enhancing the accuracy and speed of autoimmune disease diagnostics.We're grateful to work with incredible clients.
FAQs
What is the market size of the Autoimmune Disease Diagnostics Market Report in 2023?
The market size in 2023 is $8.70 Billion as reported, reflecting the global value of autoimmune diagnostic products and services for that year.
How big is the market expected to be in 2033?
The market is projected to reach $17.78 Billion by 2033 according to the report, indicating substantial expansion over the forecast period.
What is CAGR for the forecast period?
The compound annual growth rate for the 2023 to 2033 forecast period is 7.2% as specified in the report.
Which region is the fastest Growing in the Autoimmune Disease Diagnostics Market Report market?
Latin America is the fastest-growing region, projected to expand from $0.18 Billion in 2023 to $0.38 Billion in 2033, reflecting an implied 7.76% CAGR over the forecast period.
Which region is fastest Growing and at what rate?
Latin America is identified as the regional market region with an implied 7.76% CAGR, increasing from $0.18 Billion in 2023 to $0.38 Billion in 2033.
Who are the leading companies in this market?
Top firms cited include Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Roche Diagnostics, and Becton, Dickinson and Company (BD).
What end users are covered in the segmentation?
Reported end users include hospitals, clinical laboratories, home care settings, and research institutions as primary categories for diagnostic services and products.
What test types are included in the report segmentation?
The report lists laboratory tests, molecular diagnostics, and imaging techniques as principal test-type categories examined in the market analysis.
How does technology segmentation appear in the report?
Technologies are grouped into traditional diagnostic techniques, advanced diagnostic techniques, and point of care testing, reflecting varied approaches to autoimmune detection.
What automation levels are addressed?
Automation segmentation covers manual diagnostics, semi-automated diagnostics, and fully automated diagnostics to capture operational variations in laboratories.